D3-CAPS capsules 2000ME №15×2

Name:
D3-caps
Description:
Capsules soft gelatin spherical shape with a seam, transparent, light yellow color (for a dosage of 2000 ME). The main active ingredientCholecalciferol Release form Soft gelatin capsules, for capsules with a dosage of 2,000 ME: 15 capsules in a blister pack made of an opaque polyvinyl chloride / polyvinyl dichloride film and printed lacquered aluminum foil, 2 blister packs each with a leaflet in a cardboard pack; for capsules with a dosage of 5,000 ME: 10 capsules in a blister pack made of an opaque PVC/polyvinyl dichloride film and printed lacquered aluminum foil, 3 blister packs each with a leaflet in a carton pack. Dosage 2 thousand IU Indications D3-CAPS is a drug that contains cholecalciferol (vitamin D), which has a significant effect on the regulation of calcium-phosphorus metabolism, enhances calcium absorption in the intestine, calcium incorporation into osteoid and calcium release from bone tissue. Scope: – Prevention and treatment of vitamin D deficiency in adults and adolescents (from 12 to 18 years old); – As an adjunct to specific therapy for osteoporosis in patients at risk of vitamin D deficiency, preferably in combination with calcium. Dosage and Administration This medicine should always be taken exactly as directed in this package insert, or as directed by your doctor or pharmacist. If you have any doubts, please consult your doctor or pharmacist. Method of application The drug is taken orally, during meals. Prevention and treatment of vitamin D deficiency in adults and adolescents (12 to 18 years of age). The prophylactic dose of vitamin D is determined individually by the doctor, taking into account age, intake of vitamin D from other sources (food, insolation), overweight (obesity) of the patient, taking medications that affect vitamin D metabolism. The usual recommended dose is 500-1000 IU of vitamin D per day. The therapeutic dose of vitamin D and the duration of treatment are determined individually by the doctor, taking into account the initial severity of vitamin D deficiency, confirmed by laboratory, age, intake of vitamin D from other sources (food, insolation), overweight (obesity) of the patient, taking medications that affect vitamin D metabolism. The usual recommended dose is 5,000-6,000 IU of vitamin D per day. The duration of treatment is up to 6-8 weeks, followed by laboratory monitoring of the concentration of 25-hydroxycholecalciferol in the blood and the decision to continue taking or switching to a prophylactic dose. As an adjunct to specific therapy for osteoporosis in patients at risk of vitamin D deficiency: The recommended dose of vitamin D is 1000 IU daily or 7000 IU weekly or alternatively 50000 IU monthly. For elderly patients who are particularly at risk for falls and fractures, a dose equivalent to 2000 IU of vitamin D per day is recommended. Patients should receive additional calcium if dietary intake is inadequate. Some population groups are at high risk of vitamin D deficiency, and therefore for these groups it may be necessary to prescribe higher doses and monitor the concentration of 25-hydroxycholecalciferol in the blood serum: – persons suffering from alcoholism; – institutionalized or hospitalized persons; – dark-skinned; – patients with diseases of the hepatobiliary system – impaired hepatic function, cirrhosis, obstructive jaundice; – patients with malabsorption, including those suffering from inflammatory bowel disease, persistent diarrhea and celiac disease; – patients with obesity; – patients with diagnosed osteoporosis; – patients using concomitant medications (eg, anticonvulsants, glucocorticoids); – persons with limited exposure to the sun, including children. For the convenience of choosing a dose of vitamin D3, it is recommended to use drugs with different dosages (500 IU, 2,000 IU, 5,000 IU, 50,000 IU). Dosage in hepatic impairment Dose adjustment is not required. Dosage in Renal Insufficiency Vitamin D should not be used in patients with severe renal insufficiency. Infants and children (0-12 years) Not recommended for children under 12 years of age. Elderly age Vitamin D requirements may increase in older age due to decreased absorption of vitamin D, decreased ability of the skin to synthesize provitamin D, decreased sun exposure, and increased incidence of kidney failure. The dose of treatment for vitamin D deficiency in the elderly is determined individually by the doctor, depending on the course and severity of the disease. If you have taken more D3-CAPS than you should have If you or your child has taken more than necessary, contact your doctor or emergency department for risk assessment and advice. The most common overdose symptoms are: cardiac arrhythmias, thirst, production of large amounts of urine, dehydration, fatigue, bone pain, muscle weakness, impaired consciousness, anorexia, nausea, vomiting, constipation, abdominal pain, mental disorders. If you forget to take D3-CAPS Do not take a double dose to make up for the missed one, but continue treatment as recommended. If you stop taking D3-CAPS If you have any further questions about the use of D3-CAPS after you stop taking it, ask your doctor or pharmacist. Use during pregnancy and lactation During pregnancy and during breastfeeding, an adequate intake of vitamin D is required. Cholecalciferol in a daily dose of more than 500 IU can be used during pregnancy on the recommendation of a doctor if clearly necessary. D3-CAPS can be used during breastfeeding. Vitamin D passes into breast milk, this should be considered when using any additional source of vitamin D in infants. Talk to your doctor or pharmacist before using D3-CAPS if you are pregnant, breastfeeding or planning to become pregnant. Effects on fertility There are no data on vitamin D treatment and its effect on fertility. Precautions Before taking D3-CAPS, ask your doctor or pharmacist for advice if you suffer from sarcoidosis (a type of connective tissue disease that affects the lungs, skin, and joints); if you are using other medicines containing vitamin D; if you have impaired kidney function; if you are receiving treatment for heart disease. D3-CAPS is not to be taken in children under 12 years of age. Influence on the ability to drive vehicles and work with mechanisms The study of the effect on the ability to drive vehicles and work with mechanisms has not been conducted. The impact is incredible. Interactions with other drugs Tell your doctor or pharmacist if you are currently taking, have recently taken or may have taken any other medicines, including: – anticonvulsants (phenytoin) and barbiturates (used to treat epilepsy); – thiazide diuretics (to treat high blood pressure); – glucocorticosteroids (for the treatment of inflammation); – cardiac glycosides (for the treatment of heart disease), such as digoxin; – metabolites of vitamin D or its analogues (for example, calcitriol); – rifampicin and isoniazid (used to treat tuberculosis); – cholestyramine and other ion exchange resins (used to treat high cholesterol); – orlistat (a means for weight loss); – laxatives containing paraffin oil; – actinomycin (an agent used in chemotherapy); – antifungal drugs (imidazole derivatives). Contraindications – allergic to vitamin D or any of the other ingredients of this drug; – hypervitaminosis D; – hypercalcemia (increased calcium concentration in the blood plasma) and / or hypercalciuria (increased calcium concentration in the urine); – nephrolithiasis (deposition of kidney stones) and / or nephrocalcinosis (deposition of calcium salts in the kidney tissue); – severe renal failure; – children’s age up to 12 years. The active substance is cholecalciferol. One capsule contains: cholecalciferol (in the form of an oil solution of cholecalciferol 1 million IU / g) – 50 micrograms (2,000 IU) (for a dosage of 2,000 IU) or 125 micrograms (5,000 IU) (for a dosage of 5,000 IU). Excipients: medium chain triglycerides, α-tocopherol. The composition of the capsule shell: gelatin, glycerin, purified water, sodium benzoate E-211. Side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking D3-CAPS and seek immediate medical attention if you experience any of the following allergic reactions: Swelling of the face, lips, tongue, or throat Difficulty swallowing Difficulty breathing. Possible side effects may include: Metabolic and nutritional disorders: infrequently (1 case per 100 people) – hypercalcemia and hypercalciuria. Skin and subcutaneous tissue disorders: rarely (1 case per 1000 people) – itching, rash, urticaria. If you experience unwanted reactions, tell your doctor about it. This also applies to any adverse reactions not listed in this package insert. You can report adverse reactions to the information database on adverse reactions (actions) to medicinal products, including reports of ineffectiveness of medicinal products identified in the Republic of Belarus (UE “Center for Expertise and Testing in Healthcare” of the Ministry of Health of the Republic of Belarus, website rceth. by). By reporting adverse reactions, you help to get more information about the safety of the drug. Storage conditionsStore at a temperature not exceeding 25 °C. Keep out of the reach of children. Do not use the medicinal product after the expiration date indicated on the package. Buy D3-CAPS capsules 2000ME No. 15×2 Price for D3-CAPS capsules 2000ME No. 15×2